|
Market Closed -
NSE India S.E.
12:05:08 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,166.60 INR | -1.45% |
|
-2.70% | +6.46% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | Generic Pharmaceuticals | -1.45% | -2.70% | +6.46% | +19.12% | +339.34% | 6.44B |  |  |  |
- Stock Market
- Stocks
- GLENMARK Stock
- Charts Glenmark Pharmaceuticals Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
